Table 1 Baseline clinical and fasting laboratory profile of patients in control and the TAVNS groups at baseline
|  | Control (n = 10) | TAVNS (n = 20) | p |
|---|---|---|---|
Gender (M/F) | 3/7 | 7/13 | Â |
Age | 46 ± 10 | 43 ± 9 | 0.473 |
Weight (Kg) | 104 ± 22 | 105 ± 18 | 0.960 |
AC (cm) | 122 ± 13 | 119 ± 12 | 0.544 |
BMI (Kg/m2) | 37 ± 6 | 37 ± 5 | 0.854 |
SBP (mmHg) | 135 ± 21 | 137 ± 21 | 0.844 |
DBP (mmHg) | 80 ± 10 | 81 ± 10 | 0.719 |
HR (bpm) | 74 ± 10 | 72 ± 7 | 0.659 |
Glucose (mg/dL) | 105 ± 17 | 100 ± 14 | 0.875 |
Total cholesterol (mg/dL) | 201 ± 49 | 197 ± 42 | 0.832 |
HDL-c (mg/dL) | 48 ± 12 | 46 ± 10 | 0.611 |
LDL-c (mg/dL) | 125 ± 43 | 123 ± 39 | 0.946 |
Triglycerides (mg/dL) | 130 ± 42 | 141 ± 38 | 0.936 |
AST/GOT (U/L) | 24 ± 8 | 23 ± 9 | 0.791 |
ALT/GPT (U/L) | 28 ± 14 | 25 ± 7 | 0.520 |
TSH (uIU/mL) | 2.2 ± 1.0 | 2.3 ± 1.6 | 0.822 |
T4 free (uIU/mL | 1.1 ± 0.2 | 1.1 ± 0.2 | 0.697 |
Insulin (mUI/mL) | 15 ± 7 | 17 ± 7 | 0.438 |
CRP (mg/dL) | 0.6 ± 0.4 | 0.6 ± 0.3 | 0.916 |
HOMA-IR | 3.7 ± 2,0 | 4.2 ± 1.7 | 0.754 |